NCT04035798.
Methods | Randomised double‐blind placebo‐controlled study |
Participants | Estimated 120 participants with bipolar II disorder |
Interventions | Memantine 5mg (1 capsule) per day for 12 weeks |
Outcomes | Memory function Executive function Attention Processing speed Inflammatory status HDRS YMRS |
Notes | Recruiting |